According to the status of hormone receptor, including estrogen receptor (ER) and progesterone receptor (PR), and human epidermal growth factor 2 (HER2), breast cancer is categorized into distinctive molecular subtypes, guiding the diagnosis and treatment for decades (2). This evidence concerns the gene ESR1 and breast carcinoma.